Skip to main content

Advertisement

SpringerLink
Log in

Bone mineral density and adjuvant therapy in breast cancer survivors

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Compared to mean values from a US database, premenopausal breast cancer survivors (BCS) had significantly higher whole body bone mineral density (BMD) compared to age and ethnicity matched referents; higher whole body BMD was present in all premenopausal BCS, including those who received chemotherapy, tamoxifen+chemotherapy, or no adjuvant therapy. Postmenopausal BCS who had received no adjuvant therapy also had higher whole body BMD compared to similarly aged women. In contrast, hip and lumbar spine BMD values in BCS were similar to those of the population-based database.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Breast Cancer Facts and Figures 2003–2004. American Cancer Society, Atlanta, Georgia, 2003.

  • TJ Key MC Pike (1988) ArticleTitleThe role of oestrogens and progestagens in the epidemiology and prevention of breast cancer Eur J Cancer Clin Oncol 24 29–43

    Google Scholar 

  • JA Cauley FL Lucas LH Kuller MT Vogt WS Browner SR Cummings (1996) ArticleTitleBone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group JAMA 276 1404–1408

    Google Scholar 

  • RL Nelson M Turyk J Kim V Persky (2002) ArticleTitleBone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2 22

    Google Scholar 

  • Nelson DA, Darga LL, Simon MS, Severson RK: Radial bone density and breast cancer risk in white and African--American women. Osteoporos Int, 2004

  • JM Zmuda JA Cauley BM Ljung DC Bauer SR Cummings LH Kuller (2001) ArticleTitleBone mass and breast cancer risk in older women: differences by stage at diagnosis J Natl Cancer Inst 93 930–936

    Google Scholar 

  • Y Zhang DP Kiel BE Kreger LA Cupples RC Ellison JF Dorgan A Schatzkin D Levy DT Felson (1997) ArticleTitleBone mass and the risk of breast cancer among postmenopausal women N Engl J Med 336 611–617

    Google Scholar 

  • DS Buist AZ LaCroix WE Barlow E White JA Cauley DC Bauer NS Weiss (2001) ArticleTitleBone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States) Cancer Causes Control 12 213–222

    Google Scholar 

  • M Klift Particlevan der CE Laet JW Coebergh A Hofman HA Pols (2003) ArticleTitleBone mineral density and the risk of breast cancer: the Rotterdam Study Bone 32 211–216

    Google Scholar 

  • TV Nguyen JR Center JA Eisman (2000) ArticleTitleAssociation between breast cancer and bone mineral density: the Dubbo Osteoporosis Epidemiology Study Maturitas 36 27–34

    Google Scholar 

  • AC Looker ES Orwoll CC Johnston SuffixJr RL Lindsey HW Wahner WL Dunn MS Calvo TB Harris SP Heyse (1997) ArticleTitlePrevalence of low femoral bone density in older US adults from NHANES III J Bone Miner Res 12 1761–1768

    Google Scholar 

  • AT Pakilit BA Kahn L Petersen LS Abraham GA Greendale PA Ganz (2001) ArticleTitleMaking effective use of tumor registries for cancer survivorship research Cancer, 92 1305–1314

    Google Scholar 

  • PA Ganz GA Greendale L Petersen B Kahn JE Bower (2003) ArticleTitleBreast cancer in younger women: reproductive and late health effects of treatment J Clin Oncol 21 4184–4193

    Google Scholar 

  • SAS Institute Inc. SAS/STAT Users Guide, Version 8.02. Cary, NC: SAS Institute Inc., 1989

  • L Vehmanen T Saarto I Elomaa P Makela M Valimaki C Blomqvist (2001) ArticleTitleLong-term impact of chemotherapy-induced ovarian failure on bone mineral density (BMD) in premenopausal breast cancer patients. The effect of adjuvant clodronate treatment Eur J Cancer 37 2373–2378

    Google Scholar 

  • CL Shapiro J Manola M Leboff (2001) ArticleTitleOvarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer J Clin Oncol 19 3306–3311

    Google Scholar 

  • T Saarto C Blomqvist J Risteli L Risteli S Sarna I Elomaa (1998) ArticleTitleAminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients Br J Cancer 78 240–245

    Google Scholar 

  • JA Headley RL Theriault AD LeBlanc R Vassilopoulou-Sellin GN Hortobagyi (1998) ArticleTitlePilot study of bone mineral density in breast cancer patients treated with adjuvant chemotherapy Cancer Invest 16 6–11

    Google Scholar 

  • T Saarto C Blomqvist M Valimaki P Makela S Sarna I Elomaa (1997) ArticleTitleChemical castration induced by adjuvant cyclophosphamide, methotrexate, and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomized study in premenopausal breast cancer patients J Clin Oncol 15 1341–1347

    Google Scholar 

  • PF Bruning MJ Pit M Jong-Bakker Particlede A Ende Particlevan den A Hart A Enk Particlevan (1990) ArticleTitleBone mineral density after adjuvant chemotherapy for premenopausal breast cancer Br J Cancer 61 308–310

    Google Scholar 

  • K Yoneda Y Tanji N Ikeda Y Miyoshi T Taguchi Y Tamaki S Noguchi (2002) ArticleTitleInfluence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan Cancer Lett 186 223–230

    Google Scholar 

  • MB Marttunen P Hietanen A Titinen HJ Roth L Viinikka O Ylikorkala (1999) ArticleTitleEffects of tamoxifen and toremifene on urinary excretion of pyridinoline and deoxypyridinoline and bone density in postmenopausal patients with breast cancer Calcif Tissue Int 65 365–368

    Google Scholar 

  • T Saarto C Blomqvist M Valimaki P Makela S Sarna I Elomaa (1997) ArticleTitleClodronate improves bone mineral density in post-menopausal breast cancer patients treated with adjuvant antioestrogens Br J Cancer 75 602–605

    Google Scholar 

  • S Barni P Lissoni G Tancini A Ardizzoia M Cazzaniga (1996) ArticleTitleEffects of one-year adjuvant treatment with tamoxifen on bone mineral density in postmenopausal breast cancer women Tumori 82 65–67

    Google Scholar 

  • TJ Powles T Hickish JA Kanis A Tidy S Ashley (1996) ArticleTitleEffect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women J Clin Oncol 14 78–84

    Google Scholar 

  • RR Love HS Barden RB Mazess S Epstein RJ Chappell (1994) ArticleTitleEffect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years Arch Intern Med 154 2585–2588

    Google Scholar 

  • B Kristensen B Ejlertsen P Dalgaard L Larsen SN Holmegaard I Transbol HT Mouridsen (1994) ArticleTitleTamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study J Clin Oncol 12 992–997

    Google Scholar 

  • T Fornander LE Rutqvist HE Sjoberg L Blomqvist A Mattsson U Glas (1990) ArticleTitleLong-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women J Clin Oncol 8 1019–1024

    Google Scholar 

  • T Fornander LE Rutqvist N Wilking K Carlstrom B Schoultz Particlevon (1993) ArticleTitleOestrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer Eur J Cancer 29A 497–500

    Google Scholar 

  • AJ Neal K Evans PJ Hoskin (1993) ArticleTitleDoes long-term administration of tamoxifen affect bone mineral density? Eur J Cancer 29A 1971–1973

    Google Scholar 

  • RR Love RB Mazess HS Barden S Epstein PA Newcomb VC Jordan PP Carbone DL DeMets (1992) ArticleTitleEffects of tamoxifen on bone mineral density in postmenopausal women with breast cancer N Engl J Med 326 852–856

    Google Scholar 

  • IS Fentiman Z Saad M Caleffi MA Chaudary I Fogelman (1992) ArticleTitleTamoxifen protects against steroid-induced bone loss Eur J Cancer 28 684–685

    Google Scholar 

  • J Cuzick D Allen M Baum J Barrett G Clark V Kakkar E Melissari C Moniz J Moore V Parsons et al. (1992) ArticleTitleLong term effects of tamoxifen. Biological effects of Tamoxifen Working Party Eur J Cancer 29A 15–21

    Google Scholar 

  • WG Ryan J Wolter JD Bagdade (1991) ArticleTitleApparent beneficial effects of tamoxifen on bone mineral content in patients with breast cancer: preliminary study Osteoporos Int 2 39–41

    Google Scholar 

  • JA Kalef-Ezra N Pavlidis G Klouvas A Karantanas I Hatzikonstantinou D Glaros (1996) ArticleTitleElemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen Breast Cancer Res Treat 37 161–168

    Google Scholar 

  • NC Greep AE Giuliano NM Hansen T Taketani HJ Wang FR Singer (2003) ArticleTitleThe effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer Am J Med 114 653–659

    Google Scholar 

  • MW Beckmann D Jap S Djahansouzi C Nestle-Kramling B Kuschel P Dall C Brumm HG Bender (2001) ArticleTitleHormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates Oncology 60 199–206

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Carolyn Crandall, David Geffen School of Medicine at University of California, Los Angeles, Iris Cantor-UCLA Women’s Health Center, 100 UCLA Medical Plaza, Ste. 250, Los Angeles, CA, 90095-7023, USA

    C. Crandall

  2. Division of Cancer Prevention and Control Research, Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

    L. Petersen & P. A. Ganz

  3. UCLA Schools of Medicine and Public Health, Los Angeles

    P. A. Ganz

  4. Division of Geriatrics, Deptartment of Internal Medicine, David Geffen School of Medicine at University of California, Los Angeles

    G. A. Greendale

Authors
  1. C. Crandall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. A. Ganz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. A. Greendale
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Crandall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crandall, C., Petersen, L., Ganz, P.A. et al. Bone mineral density and adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat 88, 257–261 (2004). https://doi.org/10.1007/s10549-004-0804-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-004-0804-3

Keywords

Search

Navigation